Identification of novel transcripts deregulated in buccal cancer by RNA-seq

Gene

Volumn 507, Issue 2, 2012, Pages 152-158

  Sajnani, Manisha R ^a   Patel, Amrutlal K ^a   Bhatt, Vaibhav D ^a   Tripathi, Ajai K ^a   Ahir, Viral B ^a   Shankar, Vangipuram ^b   Shah, Siddharth ^b   Shah, Tejas M ^a   Koringa, Prakash G ^a   Jakhesara, Subhash J ^a   Joshi, Chaitanya G ^a  

^a Dau Shri Vasudev Chandrakar Kamdhenu Vishwavidyalaya   (India)

^b PRAMUKHSWAMI MEDICAL COLLEGE   (India)

Author keywords

Biomarkers; Buccal cancer; Gene ontology; KEGG pathway; RNA seq; RT qPCR

Indexed keywords

ACTIN; CD74 ANTIGEN; COLLAGENASE 3; DESMIN; PROTEIN P53; TRANSCRIPTOME;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DNA LIBRARY; DOWN REGULATION; GENE IDENTIFICATION; GENE MAPPING; GENETIC ASSOCIATION; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUTH CANCER; MOUTH CAVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE ANALYSIS, RNA; UP-REGULATION;

EID: 84865170090     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.036     Document Type: Article

References (52)

1. Bagchi S., Raychaudhuri P. Damaged-DNA binding protein-2 drives apoptosis following DNA damage. Cell Div. 2010, 5:3.
2. Burton J.D., et al. CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin. Cancer Res. 2004, 10:6606-6611.
3. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., Vogelstein B. 14-3-3sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999, 401:616-620.
4. Chen B.S., et al. Decreased expression of SPRR3 in Chinese human oesophageal cancer. Carcinogenesis 2000, 21:2147-2150.
5. Estilo C.L., et al. Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 2009, 9:11.
6. Feng P., Wang B., Ren E.C. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. Int. J. Biochem. Cell Biol. 2008, 40:98-109.
7. Fujioka Y., et al. MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer. J. Biol. Chem. 2001, 276:45137-45144.
8. Govekar R.B., et al. Proteomic profiling of cancer of the gingivo-buccal complex: identification of new differentially expressed markers. Proteomics Clin. Appl. 2009, 3:1451-1462.
9. Granneman S., et al. The human Imp3 and Imp4 proteins form a ternary complex with hMpp 10, which only interacts with the U3 snoRNA in 60-80S ribonucleoprotein complexes. Nucleic Acids Res. 2003, 31:1877-1887.
10. Guo X., et al. Human ribosomal protein S13 promotes gastric cancer growth through downregulating p27(Kip1). J. Cell Mol. Med. 2011, 15:296-306.
11. Han J., Kioi M., Chu W.S., Kasperbauer J.L., Strome S.E., Puri R.K. Identification of potential therapeutic targets in human head & neck squamous cell carcinoma. Head Neck Oncol. 2009, 1:27.
12. Han J., Jogie-Brahim S., Harada A., Oh Y. Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-kappaB signaling. Cancer Lett. 2011, 307:200-210.
13. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
14. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
15. Hikosaka T., et al. Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9. Peptides 2011.
16. Hough C.D., et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 2000, 60:6281-6287.
17. Huang J., et al. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer. Cancer Sci. 2010, 101:559-567.
18. Ichikawa M., Williams R., Wang L., Vogl T., Srikrishna G. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol. Cancer Res. 2011, 9:133-148.
19. Inoue M., et al. Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis. Oncol. Rep. 2005, 14:1445-1451.
20. Jose-Eneriz E.S., et al. BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia. Br. J. Haematol. 2008, 142:571-582.
21. Kumamoto K., et al. ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. Int. J. Cancer 2009, 125:1306-1315.
22. Lakhani S.A., et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006, 311:847-851.
23. Li M., et al. Thymosin beta-10 is aberrantly expressed in pancreatic cancer and induces JNK activation. Cancer Invest. 2009, 27:251-256.
24. Li H., et al. HIF-1alpha-activated ANGPTL4 contributes to tumor metastasis via VCAM-1/integrin beta1 signaling in human hepatocellular carcinoma. Hepatology 2011, 10.1002/hep.24479.
25. Liu Y.H., Lin C.Y., Lin W.C., Tang S.W., Lai M.K., Lin J.Y. Up-regulation of vascular endothelial growth factor-D expression in clear cell renal cell carcinoma by CD74: a critical role in cancer cell tumorigenesis. J. Immunol. 2008, 181:6584-6594.
26. Lowman X.H., et al. The proapoptotic function of Noxa in human leukemia cells is regulated by the kinase Cdk5 and by glucose. Mol. Cell 2010, 40:823-833.
27. Mao X. Molecular cytogenetic studies of soft tissue tumors. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1994, 16:84-92.
28. Meulmeester E., Jochemsen A.G. p53: a guide to apoptosis. Curr. Cancer Drug Targets 2008, 8:87-97.
29. Michaelis K.A., et al. Identification of growth arrest and DNA-damage-inducible gene beta (GADD45{beta}) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology 2011, 152:3603-3613.
30. Morozova O., Hirst M., Marra M.A. Applications of new sequencing technologies for transcriptome analysis. Annu. Rev. Genomics Hum. Genet. 2009, 10:135-151.
31. Mortazavi A., Williams B.A., McCue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-seq. Nat. Methods 2008, 5:621-628.
32. Motokura T., Nakamura Y., Sato H. Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignancies. BMC Cancer 2007, 7:217.
33. Nakayama T., Hirakawa H., Shibata K., Abe K., Nagayasu T., Taguchi T. Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion. Oncol. Rep. 2010, 24:599-606.
34. Old W.M., et al. Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol. Cell 2009, 34:115-131.
35. Padua D., et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008, 133:66-77.
36. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94:153-156.
37. Rautava J., Luukkaa M., Heikinheimo K., Alin J., Grenman R., Happonen R.P. Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol. 2007, 43:911-919.
38. Satou A., Hagio Y., Taira T., Iguchi-Ariga S.M., Ariga H. Repression of the c-fms gene in fibroblast cells by c-Myc-MM-1-TIF1beta complex. FEBS Lett. 2004, 572:211-215.
39. Seimiya H., Smith S. The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182). J. Biol. Chem. 2002, 277:14116-14126.
40. Sharma P., Saxena S., Aggarwal P. Trends in the epidemiology of oral squamous cell carcinoma in Western UP: an institutional study. Indian J. Dent. Res. 2010, 21:316-319.
41. Shen D.Y., et al. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver Int. 2010, 30:119-125.
42. Sho T., et al. TRIM29 negatively regulates p53 via inhibition of Tip60. Biochim. Biophys. Acta 2011, 1813:1245-1253.
43. Takikita M., et al. Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma. Anticancer. Res. 2011, 31:945-952.
44. Thiel U.J., et al. Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS. J. Oral Pathol. Med. 2011, 40:369-379.
45. Tsui K.H., Cheng A.J., Chang P.L., Pan T.L., Yung B.Y. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology 2004, 64:839-844.
46. Tuch B.B., et al. Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One 2010, 5:e9317.
47. Uhlirova M., Bohmann D. JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila. EMBO J. 2006, 25:5294-5304.
48. Vachani A., et al. A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma. Clin. Cancer Res. 2007, 13:2905-2915.
49. Ye H., et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 2008, 9:69.
50. Young M.R., Colburn N.H. Fra-1 a target for cancer prevention or intervention. Gene 2006, 379:1-11.
51. Yu C.J., et al. Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis. J. Proteome Res. 2011, 10:3778-3788.
52. Zhou A., Ou A.C., Cho A., Benz E.J., Huang S.C. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection. Mol. Cell. Biol. 2008, 28:5924-5936.